Document is current
Any future updates will be listed below
-
Authors
Fortuna, Gliceida Galarza
Banerjee, Rahul https://orcid.org/0000-0003-3781-5441
Savid-Frontera, Constanza https://orcid.org/0000-0001-8614-3528
Song, Jinming
Morán-Segura, Carlos M.
Nguyen, Jonathan V.
Lekakis, Lazaros
Fernandez-Pol, Sebastian
Samraj, Annie N.
Naresh, Kikkeri N.
Vazquez-Martinez, Mariola https://orcid.org/0009-0007-2643-7840
Baz, Rachid C.
Spiegel, Jay Y.
Mikkilineni, Lekha
Gubatan, John M.
Sidana, Surbhi https://orcid.org/0000-0003-3288-7614
de Menezes Silva Corraes, Andre
Kalariya, Nilesh M.
Patel, Krina K. https://orcid.org/0000-0002-8894-027X
Shim, Kevin G.
Fonseca, Rafael https://orcid.org/0000-0002-5938-3769
Ferreri, Christopher
Voorhees, Peter M. https://orcid.org/0000-0003-1661-718X
Richard, Shambavi
Valdes, Cesar Rodriguez
Sireesha Asoori,
Wolf, Jeffrey L.
Cowan, Andrew J.
Sborov, Douglas W.
Locke, Frederick L.
Lin, Yi https://orcid.org/0000-0002-1556-6416
Wang, Yinghong
Hansen, Doris K. https://orcid.org/0000-0002-9813-3578
- License Information
-
More Information
Article History
Received: 23 August 2024
Revised: 4 October 2024
Accepted: 9 October 2024
First Online: 16 October 2024
Competing interests
: RB reports consulting: Adaptive Biotech, BMS, Caribou Biosciences, Genentech, GSK, Janssen, Karyopharm, Legend Biotech, Pfizer, Sanofi, SparkCures; Research: Abbvie, BMS, Janssen, Novartis, Pack Health, Prothena, Sanofi. RF reports consulting: AbbVie, Adaptive, Amgen, Apple, BMS/Celgene, GSK, Janssen, Karyopharm, Pfizer, RA Capital, Regeneron, Sanofi; Scientific Advisory Board: Caris Life Sciences; Board of Directors: Antengene; Patents for certain FISH tests in MM. CF reports consulting: Janssen; research: Regeneron, Janssen; stock ownership: Affimed. PMV reports consulting: Abbvie, Astra Zeneca, BMS, GSK, Janssen, Karyopharm, Lava Therapeutics, Regeneron, Sanofi; research: Abbvie, Janssen, Regeneron. SDR reports honoraria: Janssen, BMS; steering committee involvement, Gracell Therapeutics, BMS; research support, Janssen, BMS, C4 Therapeutics, Gracell Therapeutics, Heidelberg Pharma; consulting: Genentech, Janssen, BMS. JYS reports consulting: Kite, Immpact Bio. LL reports consulting: Allogene, Sanofi. SFP reports Consulting: Cartography Biosciences; Scientific Advisory Board: Leica Biosystems. JLW reports consulting: Adaptive. AJC reports consulting: BMS, Adaptive; Research: Adaptive Biotechnologies, Harpoon, Nektar, BMS, Janssen, Sanofi, AbbVie. DWS reports consulting: GlaxoSmithKline, Janssen, Sanofi, Abbvie, Bristol Myer Squibb, Pfizer, Bioline, Arcellx, AstraZeneca, Genentech; Research: Gilead, Pfizer, Janssen, Bioline, GlaxoSmithKline, Sanofi, Amgen, Cantex, Arcellx, Roche; Steering Committee: Janssen; Data safety and monitoring: Karyopharm, and Independent Review Committee: Parexel. FLL reports a consulting or advisory role for Allogene, Amgen, Bluebird Bio, Bristol Myers Squibb/Celgene, Calibr, Cellular Biomedicine Group, Cowen, ecoR1, Emerging Therapy Solutions Gerson Lehman Group, GammaDelta Therapeutics, Iovance, Janssen, Kite, a Gilead Company, Legend Biotech, Novartis, Umoja, and Wugen; research funding from Allogene, Kite, and Novartis; and patents, royalties, other intellectual property in the field of cellular immunotherapy. P.V reports consulting or advisory role for Abbvie, AstraZeneca, Karyopharm Therapeutics, Bristol Myers Squibb, Lava Therapeutics, Sanofi, Janssen, GlaxoSmithKline; Research funding from Abbvie, Janssen, GlaxoSmithKline, and TeneoBio; Travel, accommodations, and expenses from Sanofi. DKH reports consulting: BMS, Janssen, legend Biotech, Pfizer, Karyopharm; Research: BMS, Karyopharm, Adaptive Biotechnologies, and Pentecost Myeloma Research Center. The remaining authors have no interests to disclose.
: All methods were performed in accordance with the relevant guidelines and regulations. Institutional Review Board approval was obtained for participation within the Consortium at each participating center. Patients signed informed consent at the time of CAR-T referral at each center. No identifiable data or images were shared between centers, and no identifiable data or images are present in this manuscript.
